Tampa, FL, United States of America

Manomi Perera

This inventor holds 2 USPTO granted patents and 3 published patent applications. Top assignee: Transgenex Nanobiotech Inc.. Active years: 2021-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Manomi Perera. Retrieved from https://idiyas.com/inventor/manomi-perera

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 50.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2021-2022

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Manomi Perera

Introduction

Manomi Perera is a notable inventor based in Tampa, Florida. He has made significant contributions to the field of pharmaceuticals, particularly in cancer treatment. With a total of two patents to his name, his work focuses on developing novel drug delivery systems.

Latest Patents

Perera's latest patents include the synthesis and characterization of crystalline forms of Actinomycin D. This innovation aims to enhance treatment options for cancer in humans and warm-blooded mammals. The novel forms developed by Perera include cocrystals, salts, solvates of salts, and mixtures thereof. Additionally, he has patented crystalline forms of mitomycin C, which are also designed for pharmaceutical compositions in drug delivery systems targeting human diseases.

Career Highlights

Manomi Perera is currently associated with Transgenex Nanobiotech Inc., where he continues to push the boundaries of pharmaceutical research. His work is instrumental in creating effective treatments that can improve patient outcomes in oncology.

Collaborations

Perera collaborates with talented professionals in his field, including Mazen Hanna and Jiyu Yan. Their combined expertise contributes to the advancement of innovative solutions in drug development.

Conclusion

Manomi Perera's contributions to pharmaceutical innovations, particularly in cancer treatment, highlight his role as a leading inventor in the industry. His patents reflect a commitment to improving drug delivery systems and patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…